These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Use of anabolic-androgenic steroids: we are talking prevalence rates. Kouri EM, Pope HG, Katz DL. JAMA; 1994 Feb 02; 271(5):347. PubMed ID: 8283582 [No Abstract] [Full Text] [Related]
68. Steroids: youth at risk. Ungerleider S. Harv Ment Health Lett; 2001 May 02; 17(11):4-5. PubMed ID: 11410446 [No Abstract] [Full Text] [Related]
69. The use of anabolic steroids. Lee PD. Am J Dis Child; 1990 Sep 02; 144(9):954-5. PubMed ID: 2396622 [No Abstract] [Full Text] [Related]
70. From the Alcohol, Drug Abuse, and Mental Health Administration. Goodwin FK. JAMA; 1991 Sep 25; 266(12):1619. PubMed ID: 1832194 [No Abstract] [Full Text] [Related]
74. [Relations between physical-chemical properties and effect of steroids. II. Solubility and effect of anabolic acting steroids]. Hüttenrauch R, Keiner I. Arch Pharm Ber Dtsch Pharm Ges; 1968 Nov 25; 301(11):856-62. PubMed ID: 5251143 [No Abstract] [Full Text] [Related]
75. Serum-cholesterol and anabolic steroids. Zamrazilová E, Zamrazil V. Lancet; 1966 Feb 26; 1(7435):494-5. PubMed ID: 4159712 [No Abstract] [Full Text] [Related]
79. Psychiatric effects of steroids. O'Carroll R. Lancet; 1987 May 23; 1(8543):1212. PubMed ID: 2883530 [No Abstract] [Full Text] [Related]
80. [Relations between physiochemical properties and the activity of steroids. 3. Distribution coefficient and activity of anabolic active steroids]. Hüttenrauch R, Keiner I. Arch Pharm Ber Dtsch Pharm Ges; 1968 Sep 23; 301(9):641-6. PubMed ID: 5249999 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]